1. Home
  2. CUE vs DSY Comparison

CUE vs DSY Comparison

Compare CUE & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • DSY
  • Stock Information
  • Founded
  • CUE 2014
  • DSY 2020
  • Country
  • CUE United States
  • DSY China
  • Employees
  • CUE N/A
  • DSY N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • DSY
  • Sector
  • CUE Health Care
  • DSY
  • Exchange
  • CUE Nasdaq
  • DSY Nasdaq
  • Market Cap
  • CUE 60.6M
  • DSY 58.8M
  • IPO Year
  • CUE 2018
  • DSY N/A
  • Fundamental
  • Price
  • CUE $0.76
  • DSY $1.56
  • Analyst Decision
  • CUE Strong Buy
  • DSY
  • Analyst Count
  • CUE 3
  • DSY 0
  • Target Price
  • CUE $3.00
  • DSY N/A
  • AVG Volume (30 Days)
  • CUE 206.6K
  • DSY 64.4K
  • Earning Date
  • CUE 05-08-2025
  • DSY 02-10-2025
  • Dividend Yield
  • CUE N/A
  • DSY N/A
  • EPS Growth
  • CUE N/A
  • DSY 120.37
  • EPS
  • CUE N/A
  • DSY 0.01
  • Revenue
  • CUE $9,287,000.00
  • DSY $7,323,356.00
  • Revenue This Year
  • CUE N/A
  • DSY N/A
  • Revenue Next Year
  • CUE $4.77
  • DSY N/A
  • P/E Ratio
  • CUE N/A
  • DSY $126.61
  • Revenue Growth
  • CUE 69.16
  • DSY 16.37
  • 52 Week Low
  • CUE $0.45
  • DSY $0.75
  • 52 Week High
  • CUE $2.26
  • DSY $13.47
  • Technical
  • Relative Strength Index (RSI)
  • CUE 39.49
  • DSY 55.38
  • Support Level
  • CUE $0.72
  • DSY $1.44
  • Resistance Level
  • CUE $0.89
  • DSY $1.70
  • Average True Range (ATR)
  • CUE 0.10
  • DSY 0.19
  • MACD
  • CUE 0.02
  • DSY 0.06
  • Stochastic Oscillator
  • CUE 48.59
  • DSY 80.98

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: